The ability to edit a specific locus in a genome based on targeted DNA nucleases will greatly facilitate our understanding of the function of a gene in biological research, and have many practical uses in animal biotechnology and biomedicine. Recent advances, including clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9), have substantially increased the efficiency of precise genome editing in a targeted manner. Therefore, this system has been successfully adopted for highly efficient genetic modification in diverse organisms, including animals, plants and humans, and is applicable to the efficient production of transgenic animals and model animals, as well as to breeding and research involving therapeutic potential. In addition, a base editing system has been recently developed and utilized for precise base conversion. It is composed of catalytically dead Cas9 (dCas9) and cytidine deaminase that enables both highly targeted single-base changes and local sequence diversification without double-stranded DNA cleavage. In this review, we introduce the development of genome editing technologies based on targeted DNA nucleases and the recently developed base editing system, and highlight successful research achievements indicating the potential use of programmable genome editing tools in fields of animal biotechnology.
Introduction
The ability to edit genomic sequences precisely, based on programmable DNA nucleases, such as zinc finger nucleases al., 2011; Gasiunas et al., 2012) , and make it easy to transfer into eukaryotic cells (Cong et al., 2013; . Therefore, it has been successfully adopted for precise genome editing in diverse organisms, including animals, plants and humans Ma et al., 2017; Niu et al., 2017; Ruan et al., 2017) . Ensuing from the revolutionary CRISPR-Cas9 system, a scientist has coined the term "the CRISPR Zoo" in the specialized field of animal biotechnology, because current genome editing technology is highly improved and easily utilized (Reardon, 2016) .
Most recently, a novel base editing system that enables the programmable conversion of one base pair into another and local sequence diversification without double-stranded DNA cleavage was developed Nishida et al., 2016; Hess et al., 2017) . In most known genetic disorders, the correction of a point mutation enables us to address the underlying cause of the disorder (Landrum et al., 2016) . However, Cas9-mediated genome editing via the delivery of a homology-directed repair (HDR) donor template is very low in efficiency for the correction of a point mutation. Although Cas9-mediated genome editing has been optimized for single-nucleotide editing efficiencies, reaching 60% or more in cell culture systems (Richardson et al., 2016) , this strategy generally depends on inducing a DSB. A natively generated DSB triggers small insertions or deletions (indels) that are an unintended by-product, which can have major negative functional consequences (Hess et al., 2017) . Therefore, precise base conversion based on a base editing system provides a valuable tool for genetic modification regarding highly targeted single-base changes and will draw much attention from a large number of scientists.
In this review, we introduce recent advances in genome editing technologies based on targeted DNA nucleases and a base editing system, and highlight their applications to various fields of genome engineering.
Development of programmable genome editing tools
During the past decade, programmable genome editing tools such as ZFN and TALEN have made genome editing possible.
Briefly, the first emergence of a programmable genome editing tool was ZFN, in which specific DNA-binding zinc finger proteins are fused with a nuclease domain such as the FokI endonuclease (Kim et al., 1996; Carbery et al., 2010) . As shown in Figure 1 , pairs of ZFNs specifically bind to the target region and enable the induction of DNA cleavage via FokI dimerization, resulting in the generation of DSBs. The pairing of ZFN motifs with three nucleotides depends on the amino acid composition in the genomic context (Smith et al., 2000) . Furthermore, ZFNs enable efficient gene targeting in specific genomic loci compared to homologous recombination (Porteus and Carroll, 2005) . This ZFN technology has been widely applied to the introduction of genetic modifications in diverse organisms (Urnov et al., 2010) . However, there are limitations regarding ZFN delivery into cells, including severe off-target effects and toxicity.
The second type of programmable genome editing tool is TALEN, in which the TAL effector of a DNA-binding domain derived from the pathogenic bacteria Xanthomonas is fused with a DNA cleavage nuclease domain (the same FokI endonuclease used in ZFN) (Boch et al., 2009 ). TALEN also specifically recognizes target sequences in the genome and enables the induction of DNA cleavage, resulting in the generation of DSBs similar to sequential events in ZFN (Figure 1 ).
The TAL effector, which is composed of the DNA-binding domain, contains 33-34 conserved amino acid sequences with a variable region at amino acid positions 12 and 13 called the repeat variable di-residue (RVD). The DNA specificity of a TAL effector depends on the amino acids of the RVD to recognize different nucleotides (HD binds to C, NG binds to T, NI binds to A, and NN binds to A or G) (Boch et al., 2009 ). Moreover, TALEN is a more useful and flexible tool (compared to ZFN) for editing genome sequences in the target site as a designed nuclease because each TAL effector, which contains one repeat domain, can bind to one nucleotide (Miller et al., 2011) . Therefore, TAL effectors have been widely utilized to modify a specific genomic locus, because TAL effectors can combine with activator domains such as transcriptional activators and endonucleases (Mussolino and Cathomen, 2012) . Consistent with the development of the TALEN assembly kit using golden gate shuffling, customized TALEN can be easily synthesized and used to make precise genetic modifications (Engler et al., 2009; Cermak et al., 2011; Sanjana et al., 2012) . . Development and principles of genome editing technologies: zinc finger nucleases (ZFNs), transcription activator-like endonucleases (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9). Recent advances, particularly the CRISPR-Cas9 system, have become some of the most powerful tools for genome editing to date by enhancing the DNA mutation rate through the creation of a double-stranded DNA break (DSB) at a specific locus in the genome and highly efficient genetic modification in a targeted manner. Today, almost every scientist in the world can conduct genome editing experiments to create new developments and opportunities in any animal species.
More recently, the CRISPR-Cas9 system, as a simple RNA-guided platform, has been considered the most revolutionary tool and was developed to achieve highly efficient and specific genome editing in a targeted manner. The components of CRISPR and Cas9 are derived from prokaryotic DNA, which plays an important role in acquired resistance against the invasion of plasmid DNA and phage into bacteria. These bacteria have clustered repeats called CRISPRs, which are identical to viral genomes, to defend themselves. When a virus enters a cell, a CRISPR binds to the viral RNA to disrupt it with the Cas9 protein (Barrangou et al., 2007) . The CRISPR-Cas9 system also specifically recognizes and sequentially drives DNA cleavage at the target site, resulting in the generation of DSBs (similar to ZFN and TALEN). However, unlike ZFN and TALEN, CRISPR-Cas9 does not require paired units to induce DNA DSBs at the target site. The CRISPR-Cas9 system is a type II CRISPR system that includes the Cas protein, CRISPR RNA (crRNA), trans-activating CRISPR RNA (tracrRNA), and a protospacer adjacent motif (PAM) sequence for genome editing (Jinek et al., 2012) . The PAM sequence is generally located upstream of the crRNA-binding region and guides the Cas9 protein for target recognition with a "seed" sequence within the crRNA. In detail, CRISPR-Cas9 protein-RNA complexes specifically recognize a target DNA sequence through base pairing with a guide RNA, and natively induce DNA cleavage to create a DSB at the targeted locus by the guide RNA ( Figure 1 ). Subsequently, these DSBs are involved in cellular DNA repair processes, resulting, mostly, in random indels at the site of DNA cleavage via non-homologous end joining (NHEJ) or replacement of a homologous DNA template in the DNA surrounding the cleavage site via HDR. Moreover, the CRISPR-Cas9 system has many advantages for sequence-specific genome editing, including gene knockout, gene knockin and site-specific sequence mutagenesis and corrections, making it extremely easy to synthesize crRNA and tracrRNA and comparatively simple for the construction of thousands of customized CRISPR-Cas9 systems depending on the targeted genes. In addition, the CRISPR-Cas9 system is a fast and cost-effective system for modifying the genomes of various organisms because of its simple and practical ease of use and robust cutting 
Base editing system
Most genetic diseases arise from various types of genetic or environmental mutations, such as indels, substitutions and frameshifts in the genome caused by single-nucleotide substitutions or point mutations (Men et al., 2017) . However, previous strategies used to correct point mutations are difficult to apply effectively to genetic diseases. Although genome editing mediated by CRISPR-Cas9 was optimized for single-nucleotide editing efficiencies, reaching up to 60% in cultured cells (Richardson et al., 2016) , this strategy generally depends on induced indels resulting from the cellular response to DSBs (Hess et al., 2017) . Therefore, to minimize DNA damage during genome editing and to achieve point mutation corrections without the use of an HDR donor template, a programmable base editing system to induce precise base conversion efficiently was recently developed and applied to various species. A base editing system was designed using the APOBEC (apolipoprotein B mRNA editing enzyme) 1-4 or AID (activation-induced deaminase), a group of cytidine deaminases that insert mutations in DNA/RNA as a result of their ability to deaminate cytidine to uridine (Conticello, 2008) . As shown in using the rat APOBEC (rAPOBEC) cytidine deaminase enzyme fused to the N-terminus of catalytically dead Cas9 (dCas9)
by a 16-residue peptide XTEN linker . Of the four enzymes hAID, hAPOBEC3G, rAPOBEC1, and pmCDA1, rAPOBEC1 exhibit the highest deaminase activity; connecting rAPOBEC1 to the N-terminus, not the C-terminus, of dCas9 preserves its deaminase activity. Therefore, rAPOBEC1-dCas9 has been fused to linkers of different lengths and compositions, and BE1 converted the DNA base cytosine (C) to uracil (U), which has the base-pairing properties of thymine CRISPR-mediated base editing, were used for the disruption of eukaryotic genes, with 97-99% of genes in eight eukaryotic species being precisely targeted (Billon et al., 2017) . Utilizing this system, a stop codon was generated by converting C to T at the target site of the Dmd or Tyr genes using mRNA or RNP in mouse embryos. As a result, F0 mice showed a nonsense mutation with an efficiency of 44-57%, and allelic frequencies of 100% were observed . In the near future, the base editing system will provide a valuable tool for precise genome editing with regard to highly targeted single-base changes, and could be widely used for specialized purposes regarding the production of model animals associated with amino acid substitution in any species of interest ( Figure 2 ). . Development and application of the base editing system. A single base editing system is generated by fusion of cytidine deaminase to the CRISPR-Cas9 system. Target C base is deaminized with U by three base editors (BE1, BE2 and BE3). Base excision repair (BER) reduces the intracellular base editing efficiency by removing uracil. BER can be blocked by BE2 and BE3 containing uracil DNA glycosylase inhibitor (UGI). BE3 also allows DNA repair and replication through opposite strand nicking. The base editing system provides a valuable tool for precise genome editing with regard to highly targeted single-base changes and can be widely used for specialized purposes in the production of model animals associated with amino acid substitution in any species of interest. 
Genetic engineering and applications
As mentioned above, the CRISPR-Cas9 system has many advantages in precise genome editing due to its robust, efficient and cost-effective manner. Furthermore, the CRISPR-Cas9 system has been successfully established in a number of living organisms. Here, we highlight successful research achievements and potential uses with programmable genome editing tools in various fields of genome engineering.
Chicken
Avian species have been historically used as an animal model to study early embryogenesis and organogenesis in developmental biology (Stern, 2005) , as well as in avian biotechnology (Han, 2009 
Cattle
Bovine genome modification has been mainly employed to achieve transgenesis in agricultural and biomedical fields for practical applications. In the past decade, the production of genetically modified cattle has been advanced by technological developments. Due to the lack of embryonic stem cells (ESCs) in cattle, the first successful transgenic cattle were produced by pronuclear injection (PNI); however, the efficiency was rather low and this system was unable to conduct site-specific genetic modification (Hammer et al., 1985) . To overcome the extremely low efficiency of transgenic progeny by the PNI system, sperm-mediated gene transfer and viral vector-mediated gene delivery were explored. However, these approaches These results showed that knockin mediated by CRISPR-Cas9 induced highly efficient editing of the bovine NANOG locus in bovine induced pluripotent stem cells as an alternative to pluripotent stem cells for producing genome-edited animals.
Recently, a single Cas9 nickase induced the insertion of the natural resistance-associated macrophage protein-1 (NRAMP1) gene via the SCNT system to obtain increased resistance to tuberculosis . Together, the efficient production of genetically engineered cattle based on programmable genome editing systems can provide a high-quantity production system for therapeutic proteins and improve disease resistance.
Pig
Genetically engineered swine have been used in the production of economic traits and in studies on biofunctional medicine.
Over the last century, genetic change was produced by traditional breeding that selectively developed particular phenotypic traits. Moreover, for more than two decades since the development of a variety of techniques to create gene-targeted pigs, efficient genetic alterations have been successfully employed to modify endogenous genes in zygotes or somatic cells. In swine, the first genetic modification was driven by injection of DNA into a pronucleus of a fertilized egg (Hammer et TALEN-mediated system was also used to knockout the BLG gene to reduce allergens and to create a knockin of human lactoferrin (hLF) for practical use as a bioreactor (Cui et al., 2015) . Furthermore, targeting exon 1 of the BLG locus has been efficiently applied . Goat MSTN gene editing has also been examined using the TALEN-mediated system . In 2014, the CRISPR-Cas9 system was used to induce monoallelic and biallelic gene knockout in goat primary fibroblasts with an efficiency of 9-70% (Ni et al., 2014) . The successful generation of genetically modified goats targeting MSTN and FGF5 via the CRISPR-Cas9 system resulted in targeting efficiencies of 15% and 21%, respectively . In addition, FGF5-disrupted goats exhibited increased secondary hair follicles in the skin and longer cashmere length relative to wild-type goats (Wang et al., 2016) . More recently, co-injection of Cas9 mRNA and small guide RNAs into goat embryos were used to create a BLG knockout goat with improved targeting efficiency .
Thus, genome editing technologies have been successfully adopted for precise genome editing, for practical applications regarding biomedicine and bioreactors in goats.
Other species
Non-human primates are used as essential model animals because their anatomic, physiologic, developmental, social behavior and genetic characters are highly similar to those in humans. In the field of medical research, they have been widely produced as a valuable model animal for studying Rett syndrome, a neurodevelopmental disorder, and phenotypes that included brain developmental and complex behavioral abnormalities were observed in transgenic monkeys . Although studies on transgenic monkeys are relatively rare compared to other experimental animals, the potential of primates will greatly contribute to human disease research.
Summary
Historically, targeted genome modification has been challenging. Recently, the advent of genome editing technologies, particularly the CRISPR-Cas9 system, has opened a new era in basic science, animal biotechnology, biomedicine, breeding, and therapeutic potential. The CRISPR-Cas9 system has many advantages due to its robust, efficient and cost-effective operation, and provides a valuable tool for precise genome editing. Furthermore, CRISPR-Cas9 and base editing systems have been successfully established in a number of model organisms, as well as in humans. Although there are still concerns regarding the off-target effects, ethics and genetically modified organisms in each field, today, scientists all over the world are able to conduct genome editing experiments to create new possibilities and opportunities from diverse species of interest.
Finally, we are certain, in the foreseeable future, that programmable genome editing tools will show tremendous potential in various fields of genetic engineering.
